Palomar Presses Claim to Invalidate MEHL/Biophile Hair Removal Patent
From: PR Newswire
BEVERLY, Mass., April 29 /PRNewswire/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI) today announced that it will be seeking in New Jersey a declaration that Palomar's Epilaser(TM) laser-based hair removal system does not infringe on MEHL/Biophile International Corp.'s (Nasdaq: MEHL) laser hair removal method, and furthermore, that Dr. Nardo Zaias' laser hair removal patent, licensed to MEHL/Biophile's Selvac subsidiary, is invalid.
As Palomar announced on March 12, 1997, MEHL/Biophile and Palomar had separately filed similar lawsuits, one in New Jersey and one in ...
About Our Articles: We've partnered with Highbeam Research to provide these article excerpts for your research needs. However, due to copyright laws, we cannot publish the whole article. To view these articles in full length you'll need to use the link above to access the free trial at Highbeam.